G.Barekat Pharm (XTEH:BRKT1) Total Current Assets : IRR26,786,837 Mil (As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. G.Barekat Pharm's total current assets for the quarter that ended in Mar. 2017 was IRR26,786,837 Mil.

G.Barekat Pharm Total Current Assets Historical Data

The historical data trend for G.Barekat Pharm's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Total Current Assets Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Total Current Assets

26,786,837.00

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Total Current Assets	-	26,786,837.00

G.Barekat Pharm Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

G.Barekat Pharm's Total Current Assets for the fiscal year that ended in Mar. 2017 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	3821390	+	13834845	+	6877322	+	2253280
	=	26,786,837

G.Barekat Pharm's Total Current Assets for the quarter that ended in Mar. 2017 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	3821390	+	13834845	+	6877322	+	2253280
	=	26,786,837

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

G.Barekat Pharm (XTEH:BRKT1) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

G.Barekat Pharm's Liquidation Value for the quarter that ended in Mar. 2017 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3821390	-	24253612	+	0.75 * 12912311	+	0.5 * 6877322
=	-7,309,328

G.Barekat Pharm Total Current Assets Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines